Speaker illustration

Doctor Eduard Sidelnkov

Amgen Europe GmbH, Zug (Switzerland)

A longitudinal evaluation of cardiovascular risk factors, treatment patterns, and outcomes in patients with documented cardiovascular disease treated with lipid lowering therapy in the United Kingdom

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Public Health

Session: Cardiovascular Disease Prevention and Treatment: What Drives Change?


This platform is supported by

logo Novo Nordisk